Evidence showed that the expression of CTLA-4 has a different prognostic effect in metastatic NSCLC lymph nodes versus primary tumors, which is mediated by phenotypical differences between the tumor microenvironments of lymph nodes and primary tumors [233]. The gene discussed is CTLA4; the disease is non-small cell lung carcinoma.